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SUMMARY 
Background - Preoperative autologous blood do-
nation (PABD) is utilized to circumvent the use of 
allogenic blood for various reasons. 
Objective -  To describe the distribution in terms 
of demographic characteristic, trends in participa-
tion and result of screening test of the PABD pro-
gramme of the Accra Area Blood Center from 
1993-2003.   
Design and Setting Retrospective descriptive 
study of PABD in patients scheduled for a variety 
of elective surgical procedures. 
Setting- Different levels of institutional health 
care in Accra, Ghana. 
Methods Data from existing records of patients 
who had participated in PABD were collated and 
analyzed 
Results Five hundred and forty six (546) females 
and 89 males participated, with ages ranging be-
tween 14-74 years. Majority of the patients 
(76.7%) underwent gynaecological surgery. A 
total of 330 (52%) donated one unit only, and 299 
(47.1%) donated two units. Majority of the pa-
tients (56.4%) had the surgery at the Korle-Bu 
Teaching Hospital (KBTH). Of the donations, 21 
(3.3%), 1 (0.2%), 1 (0.3%) and nil were positive 
for HBV, HIV I & II, HCV and VDRL respec-
tively. A total of 848 (89.4%) autologous cross-
matched units were issued out. There was a steady 
progressive increase in participation. 
Conclusion Mainly adult females scheduled for 
gynaecological surgeries in KBTH participated, 
while almost equal proportions donated one or two 
units of blood which meets the blood needs of 
most elective surgeries. Therefore healthy patients 
going for elective surgeries in regions with limited 
blood supply must be encouraged to enter a PABD 
Programme. Further studies in this field should 
evaluate motivational factors for participation 
 
Keywords: Autologous donation, Gynaecological 
surgery, Accra, Blood transfusion 
 
INTRODUCTION 
Autologous blood transfusion (ABT) is defined by 
the council of Europe as a transfusion in which the 
donor and recipient is the same person, who will 
be transfused with pre-deposited blood or its com-
ponents1.  The forms of ABT currently available 
are Preoperative Autologous Blood Donation 
(PABD), Acute Normovolemic Haemodilution 
(ANH) and Blood Salvage (BS) as intra-operative 
or postoperative procedures. Autologous blood can 
be used alone or in combination with allogenic 
blood. ABT is considered where blood loss requir-
ing transfusion has occurred or is anticipated. In 
emergency, it may be the only readily available 
source of blood, as in the management of ruptured 
ectopic pregnancy in deprived district hospitals.  
 
PABD involves the collection and storage of pa-
tient’s blood prior to a planned surgery. This op-
tion is an alternative to allogeneic blood for pa-
tients whose general condition fall within donor 
guidelines and whose intraoperative blood re-
quirements can be reasonably and accurately as-
sessed preoperatively. A unit of the patient’s blood 
is collected at intervals of seven days in the period 
leading to surgery. The blood is tested, labelled 
and stored under the same conditions as allogeneic 
blood. Autologous blood is made available on the 
day of surgery for transfusion to the patient. 
PABD may be utilized for a variety of planned 
surgical procedures. Before the advent of 
HIV/AIDS, a number of reasons were advanced in 
support of ABT. These included reduction of the 
need for recruited blood donors, reduction of the 
risk of transmission of hepatitis and reduction of 
the incidence of recipient alloimmunisation2. In the 
early years of the HIV scare, ABT was advocated 
as a means of reducing HIV transmission but later, 
this lost some of its impact because of higher cost 
and the improvement in safety procedures in blood 
collection, testing and transfusion. PABD had been 
used as a source of blood supply for patients with 
antibodies to high incidence blood group antigens 
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and also for patients with rare blood groups2. The 
use of BS is rapidly increasing due to improved 
methods of collection, washing and reinfusion. BS 
using crude methods had been in use since 19252. 
Shed blood in closed, sterile serosal cavity was 
collected, filtered through layers of sterile gauze 
and reinfused2,3.   The need for use of PABD in 
Accra arose when many healthy patients coming 
for gynaecological surgery could not get blood pre 
deposited on their behalf. They resorted to either 
asking for favours from the blood centre, thereby 
putting pressure on limited stock levels or hiring 
commercial donors for a fee which compromised 
the safety of the blood stock. A decision was taken 
to educate healthy females scheduled for myomec-
tomy or hysterectomy to donate blood for them-
selves. Patients for other planned surgeries were 
later encouraged to join the programme. 
 
 The Accra Area Blood Centre (AABC) sited at 
Korle Bu Teaching hospital (KBTH) is responsible 
for the blood transfusion needs of all patients in 
hospitals in Greater Accra and parts of Central and 
Eastern regions of Ghana. The objective of this 
study was to analyse the PABD programme over 
the period it had been operated to determine its 
scope, usefulness and impact to fashion out its 
future direction. 
 
MATERIALS AND METHODS 
Donors/Patients    
From February 1993 to December 2003, all 
healthy patients for myomectomy or hysterectomy 
calling at the AABC to solicit for assistance for 
blood donors for their planned surgery were re-
cruited into a PABD programme. In the course of 
time healthy patients for other planned surgeries 
were also recruited into the programme. Patients 
were first given an educational talk on their health, 
the advantages and disadvantages of PABD and 
the requirements to enter the programme. The 
same criteria for selection of voluntary blood do-
nors were used except that a prospective do-
nor/patient must have an initial and subsequent 
haemoglobin (Hb) level of ≥11gm/dl. No strict 
weight requirements were applied. Suitable ad-
justment to 10% total blood volume and antico-
agulant quantity were made for donors with a 
weight of less than 50kgs (Immediately prior to 
venepuncture, some of the anticoagulant in the bag 
is allowed to drain away into a container by grav-
ity, with care being taken not to allow air to enter 
the bag). No strict age limit was applied. Prospec-
tive donors/patients with ages greater than 70yrs or 
less than 16yrs were accepted after a careful clini-
cal assessment and consultation with their attend-
ing physician. 
 
Controlled mild to moderate hypertensives on 
medication, diabetics on oral hypoglycaemic 
agents and asthmatics in remission were also ac-
cepted. In addition, there must be sufficient time 
before surgery to enable the patient to donate the 
number of units required. The date for the surgery 
should be fixed and in the case of minors they 




A PABD request form which is a short communi-
cation between the doctor at the centre and the 
attending surgeon was completed after the pa-
tient’s surgeon, anaesthetist, or the doctor at the 
blood center had educated the patient on the option 
of autologous transfusion. Informed consent of the 
patient and parents in the case of minors was ob-
tained. The completed form was then sent to the 
blood center. Prospective donors/patients were 
clinically assessed by a doctor at the blood centre 
for suitability to enter the programme. Blood col-
lections were scheduled at weekly intervals, with a 
week between the last collection and the date for 
the surgery. All donors/ patient took oral iron sup-
plements as ferrous sulphate 65mg elemental iron 
three times daily for 2-4weeks, starting 1-2 weeks 
before the procedure. The Hb was checked before 
each collection and the patient was deferred if it 
was below 11gm/dl.  
 
Patients with acceptable Hb levels then went 
through pre-donation counseling, medical assess-
ment and a clinical form was completed. Educa-
tion of patients who enrolled in the programme 
was paramount to the success of the procedure. 
This included advantages of the option of autolo-
gous transfusion and the steps involved in blood 
donation.  Pre-donation counseling covered all 
aspects of microbiological screening tests to be 
performed on the donated blood as well as group-
ing and cross-matching with patient sample on the 
day of issue.  Most patients that enrolled in this 
programme wanted reassurance that they would 
receive their own blood and not homologous 
blood. The possibilities of the results that might be 
obtained were discussed. The results were also 
discussed during post-donation counseling. Pa-
tients whose blood tested positive for Hepatitis B 
and C antibodies had the option of being trans-
fused with their own blood or with homologous 
blood. In the blood collection procedure, each 
blood bag was carefully labelled as ‘autologous’ 
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and with a special batch number  e.g. 
JKA1/0021/04 signifying the donor’s initials, 
number of donation for particular surgery, number 
in autologous register and year of donation. This 
was explained to the donor/patient adequately to 
reassure them before collection began. The proce-
dure for blood collection was as for collection of 
allogeneic blood, with all blood collections done 
under the supervision of a doctor. A special slip 
(Figure 1) was then given to the patient when the 
collection(s) were completed. ABO, Rh ‘D’ group-
ing and all available microbiological screening 
tests were performed on donor blood samples. All 
donor blood was tested at the early stages of the 
programme for HIV I & II antibodies and Hepatitis 
B surface antigen only. Later on in the programme, 
VDRL for syphilis was reintroduced and Hepatitis 
C virus (HCV) antibody testing was introduced. 
Corresponding blood bags were labelled with the 
results. Units confirmed reactive for HBsAg, anti 
HCV or VDRL were carefully labelled as biohaz-
ard “restricted only to autologous patient’s use” 
whilst units confirmed reactive for anti-HIV were 
discarded appropriately. Autologous blood was 
stored in a dedicated compartment in the blood 
storage refrigerator.  
 
Blood Transfusion Procedure  
A completed blood request form, together with 
autologous blood collection slip and 5mls of pa-
tient’s blood sample were sent to the blood bank 
laboratory 48hours prior to the surgery. Compati-
bility testing was performed for each unit of 
autologous blood against patients’ blood sample. 
Autologous blood was then issued out on the day 
of the surgery. Patient’s surgeon completed a spe-
cifically designed form on the day of discharge of 
the patient. This was sent to the doctor at the blood 
center. Following confirmation from the surgeon 
that the patient would no longer require blood 
transfusion, all units of autologous blood labelled 
as biohazard were discarded whereas units nega-
tive for all microbiological markers were crossed 
over to the regular bank pool for homologous use. 
 
Analysis 
Records covering 10 years 10 months were com-
piled and analysed according to age, sex, hospital 
and type of surgery on a yearly basis. 
 
RESULTS 
A total of 672 patients were enrolled in the PABD 
Programme from February 1993 to December 
2003. Of the total number, 37 patients (5.5%) were 
excluded because they failed the clinical screening. 
The main reason for failure was low haemoglobin 
level as a result of menorrhagia. 
 
The remaining 635 patients comprised 89 males 
and 546 females. They were aged between 14-74 
years, mean of 41.7 years, with a male: female 









Figure 2 Age distribution of donors / patients who en-
rolled in the Preoperative Autologous Blood Donations 
programme. 
  
Table 1 shows the distribution of patients undergo-
ing PABD for various types of planned surgery.  
 















Neurosurgery 52 8. 2 
Orthopaedic Surgery 37 5.8 
General  Surgery 21 3.3 
Maxillo-facial Surgery 20 3.1 
Genitourinary  Surgery 13 2.0 
Plastic Surgery 4 0.6 








Patients undergoing gynaecological procedures 
were the largest subgroup, representing 76.7% of 
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the participants. Gynaecological procedures per-
formed were myomectomy or hysterectomy for 
uterine fibroids, post menopausal bleeding, uterine 
prolapse, cervical lesions, removal of ovarian tu-
mours, blocked fallopian tubes and repair of 
vesico-vaginal fistulas (VVF). 
 
Neurosurgical procedures were mainly for cervical 
kyphoscoliosis, various forms of spinal stenosis, 
congenital scolosis/kyphosis and orthopaedic pro-
cedures were for spondylolisthesis and osteoarthri-
tis (hip and or knee). 
 
General surgical procedures were for removal of 
goiters or gallbladder, and repair of anal fistula, 
whilst maxillo-facial procedures were performed 
for mandibular, maxillary and parotid tumour re-
sections. Genitourinary surgery performed in-
cluded prostatectomy and removal of bladder or 
kidney mass. Plastic surgery procedures included 
correction for breast hypertrophy and excision of 
various tumours. The only eye surgery procedure 
was an orbitomy. 
 
A total 330 (52%) patients donated one unit of 
blood, 299 (47.1%) donated two units and 6 
(0.9%) donated three units.  The single unit dona-
tions were analysed to find out the category of 
surgery for which donations were made. The fre-
quency of the one unit donations were as follows: 
Gynaecological surgery 281 (85.2%), neurosur-
gery 14 (4.2%), orthopaedic surgery 13 (3.9%), 
genitourinary surgery 5 (1.5%), faciomaxillary 
surgery 4 (1.2%), the rest being plastic and eye 
surgery as 2 (0.6%) and 1 (0.3%) respectively. The 
yearly enrolment of patients who participated in 
the PABD programme from February 1993 to De-




Figure 3 Yearly enrolment of patients who participated 
in the programme from February 1993 to December 
2003.   
 
There is a gradual rise in the number who entered 
the programme. There was no doctor at the centre 
from late 1997 to the first half of 1999 hence the 
fall during the period. 
 
Patients who enrolled in the programme increased 
from 10 in 1993 to 166 in 2003. Patients who par-
ticipated in the programme were initially from the 
Korle Bu Teaching Hospital (KBTH). In the 
course of the observation period, after some mod-
est education on the option of autologous transfu-
sion, patients from other hospitals in the catchment 
area joined in the programme. Table 2 shows the 
hospitals from which patients originated. One pa-
tient reported from Battor Hospital in the Volta 
region. 




















Quasi Govt. Hospitals 13 2.0 
Other Govt. Hospitals (Accra) 23 3.6 







KBTH refers to Korle Bu Teaching Hospital. 
Quasi Govt. Hospital refers to Public hospital outside Ministry of Health 
Other Govt. Hospital refers to Ministry of Health hospitals beside KBTH. 
 
The microbiological screening results of donated 
blood for the routine microbiological markers HIV 
I & II, HBV, HCV, VDRL were as follows; posi-
tive HBV 21 (3.3%), positive HCV 1 (0.3%), posi-
tive VDRL 0 (0%), positive HIV I & II 1 (0.2%). 
A total of 848 units of compatible blood (89.4%) 
were issued out during the period after cross-
matching from the blood centre laboratory to re-




The importance of autologous blood transfusion 
had been increasingly recognized in the last 
25years4. The percentage of autologous blood 
transfused yearly in USA rose from 0.8% in 1982 
to 8.1% in 19925. In Italy and Germany the yearly 
percentages of autologous blood transfused in 
2000 were 7.8% and 6.4% respectively1. PABD 
had been used as a tool for conservation of bank 
blood for cardiopulmonary and orthopaedic opera-
tions. Its introduction at the Accra Area Blood 
Centre for Korle Bu Teaching Hospital patients 
was mainly for blood conservation. Seventy per-
cent (70%) of blood donations to the Accra Area 
Blood Centre (AABC) were pre-deposit family 
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donations for planned surgery or replacement do-
nations. Patients’ relatives deposited blood before 
patients were booked for surgery. In over 30% of 
patients, the blood was not utilized. This non utili-
zation was carried over into the PABD. 
 
The main goal of a preoperative autologous blood 
donation programme in most centers is to reduce 
or eliminate the need for homologous blood trans-
fusion.  While PABD represents good transfusion 
practice for surgical procedures likely to require 
blood transfusion, its application in surgical pro-
cedures unlikely to require blood transfusion is 
controversial6,7,8.  Potential candidates for PABD 
prior to surgery include any patient scheduled for a 
procedure for whom cross-matched blood is re-
quested, indicating a likelihood of requiring blood 
transfusion according to a maximum surgical 
blood ordering schedule. It had been observed that 
in over 60% of gynaecological surgery, collected 
autologous blood was not used9. Of those who 
received transfusion, 61% were given one unit 
only9. In that study it was observed that if the 
probability of a patient receiving a transfusion 
with the surgery is less than 5% there was no need 
for a PABD. This was common with gynaecologi-
cal and plastic surgery. Fifty-two percent (52%) of 
the patients in this study donated one unit towards 
their surgeries. In 74.1% of the cases, surgeons 
requested single unit donation whilst the rest had 
Hb levels below the accepted level of 11.0gm/dl at 
subsequent donations and were therefore excluded 
from further donation.  Two patients who partici-
pated in the PABD programme also had Acute 
Normovolemic Haemodilution (ANH) in theatre 
on the day of surgery. ANH is essentially an an-
aesthetic procedure that involves the removal of 
patient's red blood cells by controlled removal of 
whole blood and the simultaneous replacement 
with a combination of colloid or crystalloid to 
maintain adequate circulatory volume. This proce-
dure is usually performed in the operating room in 
the perianaesthesia period with standard or inva-
sive monitoring in place. The advantage of ANH 
in addition to providing autologous blood is that it 
brings about improved blood flow distribution 
within the microvascular network and enhanced 
tissue perfusion10. These single unit donations 
were mainly for gynaecological surgery known for 
low likelihood of transfusion but which in the 
KBTH setting blood had to be pre-deposited.  In 
this programme autologous blood donation in-
creased from 10 (0.08% of total donations) in 1993 
to 160 (0.9% of total donations) in 2003. Gynaeco-
logical surgery is by far the largest category con-
stituting 76.7%. Despite this increase the number 
is very small, being less than 1% of the total blood 
donations for that year (NBTS annual report). Over 
the years, there was a gradual expansion of the 
programme to cover other hospitals and also for 
non gynaecological surgery. About thirty-seven 
percent (37.8%) of the patients were from private 
hospitals. This is significant, considering that be-
tween 8% to 17% of total blood collections for 
2002-2003 were issued to private hospitals com-
pared to 37.8% of autologous. The frequency of 
microbiological markers was not remarkably lower 
than in the voluntary donor populations except for 
HIV which was low at 0.3%. 
 
The advantages of PABD are enormous. These are 
that patients benefit from knowing that they were 
actively involved in their own treatment and the 
phlebotomy process also stimulates the bone mar-
row to increase cell production. This stimulated 
blood production is thought to speed up a patient’s 
recovery postoperatively11.  PABD had been shown 
to result in accelerated peri-operative erythropoe-
isis12. The patient’s privacy with respect to the 
surgery was assured since the blood needs towards 
the particular surgery were donated by him/her. 
PABD has the advantage of ensuring reduced 
pressure on bank blood which can then be used for 
the blood needs of medical and surgical emergen-
cies. PABD as a method of blood transfusion pre-
sents no risk of transmitted viral infection or de-
velopment of alloantibodies, avoids the alleged 
problem of increased postoperative infections and 
enhanced risks of tumour recurrence13, and is an 
outlet for people with rare or unusual blood group. 
 
PABD however requires considerable planning 
and organization.  The criteria for patient eligibil-
ity are well defined and some enthusiastic patients 
will just not be fit enough to be included in the 
programme. One major disadvantage realized in 
this study is inappropriate usage which results in 
wastage of blood. Surgeons should not transfuse 
autologous blood simply because it is available. 
This wastage was also observed by others9.  An-
other drawback was the inability of clinicians to 
provide desired information on the fate of the 
blood collected. An autologous blood transfusion 
form specifically designed for the purpose to indi-
cate the outcome of blood was not completed in 
most instances. The cost of autologous blood 
transfusion has been a drawback in many centers 
but this is because in these centers the unused 
blood is discarded5. This is not an issue in this 
centre where those unused units which are nega-
tive with microbiological screening are added to 
the bank pool. 
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Iron replacement alone or together with marrow 
stimulation with erythropoietin is required. The 
latter is required when aggressive PABD is antici-
pated, by which 1000mls blood is removed a 
week. Erythropoietic response to serial phlebot-
omy over an interval may result in iron-restricted 
erythropoiesis, endogenous erythropoietic re-
sponse or both14,15 
 
Procedural and clerical errors must be consciously 
avoided and therefore the same conditions ob-
served for allogeneic donations are ensured for 
autologous blood donation. Bacterial contamina-
tion is a remote risk just as allogeneic blood. Simi-
lar conditions are observed during blood collec-




It is observed that preoperative autologous blood 
donation had increased over the ten year period. It 
is, however, less than 1 percent of blood collected. 
It is a solution for providing blood needs of many 
healthy patients requiring planned surgery. Sur-
geons and Gynaecologists working in teaching 
hospitals and regional hospitals are encouraged to 
educate these healthy patients to opt for PABD. 
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